Welcome to the Learning Center Library—your source for information about the role of lipoprotein particles in cardiovascular disease risk management.
Select the resource, either by category or media type, you would like to view.
Dr. Wright explains normal lipid and lipoprotein metabolism and the variations that occur in patients with hypertriglyceridemia and insulin resistance that have an impact on LDL particle number.
Measuring the amount of cholesterol in a patient’s low-density lipoprotein (LDL) cholesterol fraction may not be the best gauge of the risk attributable to LDL.
This MOA video defines the roles of LDL-P and cholesterol in cardiovascular disease risk. [Video length: 00:30 seconds].
This video provides an outline of the theory that there is no reliable relationship between cholesterol measured and the number of lipoprotein particles present, based on the idea that the amount of cholesterol per particle is highly variable. [Video length: 4:25 minutes]
Dr William Cromwell provides an overview of the relationship between lipoproteins and atherosclerosis. [Video length: 5:10 minutes]
This presentation outlines the pathophysiology of lipoprotein particles and their relationship to atherogenic plaque formation.
Fill out the form below to request a consultation with a certified lipidologist who can answer lipoprotein-related questions you may have.
Physician consultation requests should be limited to questions regarding utilization of low-density lipoprotein particles(LDL-P) for patient management. It is preferred that you have an actual patient case study or clinical application scenario to review with the expert. For all other questions, please contact us.
* = required
Support for this website and its content is provided by LipoScience Inc.
©2012 LipoScience Inc. All rights reserved.